Published in J Immunol on December 15, 2000
MHC heterozygosity confers a selective advantage against multiple-strain infections. Proc Natl Acad Sci U S A (2002) 2.45
The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype. J Virol (2002) 2.05
Major histocompatibility complex genomics and human disease. Annu Rev Genomics Hum Genet (2013) 1.75
MHC polymorphism under host-pathogen coevolution. Immunogenetics (2004) 1.61
In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). Retrovirology (2009) 1.58
HTLV-1 integration into transcriptionally active genomic regions is associated with proviral expression and with HAM/TSP. PLoS Pathog (2008) 1.45
High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response. Blood (2007) 1.43
In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection. Proc Natl Acad Sci U S A (2007) 1.36
HLA class I binding of HBZ determines outcome in HTLV-1 infection. PLoS Pathog (2010) 1.28
Heterozygote advantage fails to explain the high degree of polymorphism of the MHC. Immunogenetics (2004) 1.22
Does intra-individual major histocompatibility complex diversity keep a golden mean? Philos Trans R Soc Lond B Biol Sci (2009) 1.20
The adaptive immune system in diseases of the central nervous system. J Clin Invest (2012) 1.17
Susceptible and protective HLA class 1 alleles against dengue fever and dengue hemorrhagic fever patients in a Malaysian population. PLoS One (2010) 1.16
Neuroimmunity of HTLV-I Infection. J Neuroimmune Pharmacol (2010) 1.11
Retrovirally induced CTL degranulation mediated by IL-15 expression and infection of mononuclear phagocytes in patients with HTLV-I-associated neurologic disease. Blood (2008) 1.07
Major histocompatibility complex heterozygosity reduces fitness in experimentally infected mice. Genetics (2007) 1.03
KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection. PLoS Pathog (2011) 1.02
Post-transplantation HTLV-1 myelopathy in three recipients from a single donor. J Neurol Neurosurg Psychiatry (2003) 1.00
Quantification of the virus-host interaction in human T lymphotropic virus I infection. Retrovirology (2005) 0.99
HLA class I allele promiscuity revisited. Immunogenetics (2011) 0.99
Degenerate T-cell recognition of peptides on MHC molecules creates large holes in the T-cell repertoire. PLoS Comput Biol (2012) 0.97
Massive depletion of bovine leukemia virus proviral clones located in genomic transcriptionally active sites during primary infection. PLoS Pathog (2013) 0.97
Effect of human leukocyte antigen heterozygosity on infectious disease outcome: the need for allele-specific measures. BMC Med Genet (2003) 0.97
Mate preferences and infectious disease: theoretical considerations and evidence in humans. Philos Trans R Soc Lond B Biol Sci (2011) 0.95
Genetic polymorphisms in the PTPN13 gene and risk of squamous cell carcinoma of head and neck. Carcinogenesis (2009) 0.95
HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection. Semin Cancer Biol (2013) 0.94
Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru. Clin Exp Immunol (2006) 0.94
Immunogenetics and the Pathological Mechanisms of Human T-Cell Leukemia VirusType 1- (HTLV-1-)Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP). Interdiscip Perspect Infect Dis (2010) 0.91
An asymmetric model of heterozygote advantage at major histocompatibility complex genes: degenerate pathogen recognition and intersection advantage. Genetics (2008) 0.89
Presentation of human T cell leukemia virus type 1 (HTLV-1) Tax protein by dendritic cells: the underlying mechanism of HTLV-1-associated neuroinflammatory disease. J Leukoc Biol (2009) 0.87
Associations between the human MHC and sustained virologic response in the treatment of chronic hepatitis C virus infection. Genes Immun (2008) 0.87
Immunopathogenesis of human T-cell leukemia virus type-1-associated myelopathy/tropical spastic paraparesis: recent perspectives. Leuk Res Treatment (2012) 0.86
HTLV-1 tax specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complications. PLoS Negl Trop Dis (2011) 0.86
HLA-Cw7 zygosity affects the size of a subset of CD158b+ natural killer cells. J Clin Immunol (2002) 0.86
Epidemiological and genetic correlates of severe acute respiratory syndrome coronavirus infection in the hospital with the highest nosocomial infection rate in Taiwan in 2003. J Clin Microbiol (2006) 0.84
Role of resident CNS cell populations in HTLV-1-associated neuroinflammatory disease. Front Biosci (Landmark Ed) (2009) 0.84
How does HTLV-1 cause adult T-cell leukaemia/lymphoma (ATL)? Curr Opin Virol (2015) 0.82
Lack of evidence to support the association of a single IL28B genotype SNP rs12979860 with the HTLV-1 clinical outcomes and proviral load. BMC Infect Dis (2012) 0.82
Association between HLA Class I Alleles and Proviral Load in HTLV-I Associated Myelopathy/Tropical Spastic Paraperesis (HAM/TSP) Patients in Iranian Population. Iran J Basic Med Sci (2013) 0.80
Replication of the association of HLA-B7 with Alzheimer's disease: a role for homozygosity? J Neuroinflammation (2006) 0.80
Association analysis of HSP70A1A haplotypes with heat tolerance in Chinese Holstein cattle. Cell Stress Chaperones (2013) 0.80
HLA polymorphisms and detection of kaposi sarcoma-associated herpesvirus DNA in saliva and peripheral blood among children and their mothers in the uganda sickle cell anemia KSHV Study. Infect Agent Cancer (2010) 0.79
The efficiency of the human CD8+ T cell response: how should we quantify it, what determines it, and does it matter? PLoS Comput Biol (2012) 0.79
Association between HLA alleles and HAM/TSP in individuals infected with HTLV-1. J Neurol (2013) 0.78
The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP). Iran J Basic Med Sci (2013) 0.78
IL28B gene polymorphism SNP rs8099917 genotype GG is associated with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-1 carriers. PLoS Negl Trop Dis (2014) 0.78
Ex vivo analysis of human T lymphotropic virus type 1-specific CD4+ cells by use of a major histocompatibility complex class II tetramer composed of a neurological disease-susceptibility allele and its immunodominant peptide. J Infect Dis (2007) 0.78
Geographical distribution and disease associations of the CD45 exon 6 138G variant. Immunogenetics (2006) 0.77
Molecular characterization of HTLV-1 gp46 glycoprotein from health carriers and HAM/TSP infected individuals. Virol J (2013) 0.77
Interference with immune function by HTLV-1. Clin Exp Immunol (2004) 0.76
In contrast to HIV, KIR3DS1 does not influence outcome in HTLV-1 retroviral infection. Hum Immunol (2012) 0.76
HLA class I alleles in HTLV-1-associated myelopathy and asymptomatic carriers from the Brazilian cohort GIPH. Med Microbiol Immunol (2008) 0.76
Genetic Markers of the Host in Persons Living with HTLV-1, HIV and HCV Infections. Viruses (2016) 0.76
A sequence-based approach demonstrates that balancing selection in classical human leukocyte antigen (HLA) loci is asymmetric. Hum Mol Genet (2012) 0.76
Association between HLA-DQB1 alleles and HAM/TSP patients in Khorasan Province. Iran J Basic Med Sci (2014) 0.75
Cytokine profile and proviral load among Japanese immigrants and non-Japanese infected with HTLV-1 in a non-endemic area of Brazil. PLoS One (2017) 0.75
Nation-wide epidemiological study of Japanese patients with rare viral myelopathy using novel registration system (HAM-net). Orphanet J Rare Dis (2016) 0.75
Genetic variability in the extracellular matrix protein as a determinant of risk for developing HTLV-I-associated neurological disease. Immunogenetics (2006) 0.75
A Peruvian family with a high burden of HTLV-1-associated myelopathy/tropical spastic paraparesis. BMJ Case Rep (2015) 0.75
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci U S A (1997) 13.47
Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature (1991) 10.85
HTLV-I associated myelopathy, a new clinical entity. Lancet (1986) 10.49
Hemodynamic shear stress and its role in atherosclerosis. JAMA (1999) 9.27
Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci U S A (1997) 8.05
Evolution and transmission of stable CTL escape mutations in HIV infection. Nature (2001) 6.57
Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens (1995) 6.33
The wMel Wolbachia strain blocks dengue and invades caged Aedes aegypti populations. Nature (2011) 4.75
Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet (1996) 4.33
Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell (1993) 4.15
Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res (1993) 3.87
Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection. J Virol (1997) 3.79
The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection. J Virol (1997) 3.77
The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development. Development (1999) 3.74
The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol (1997) 3.70
The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J (2000) 3.64
Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature (1995) 3.61
Population dynamics of immune responses to persistent viruses. Science (1996) 3.49
Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J Exp Med (2001) 3.44
Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol (1998) 3.32
Infection dynamics on scale-free networks. Phys Rev E Stat Nonlin Soft Matter Phys (2001) 3.12
Csx: a murine homeobox-containing gene specifically expressed in the developing heart. Proc Natl Acad Sci U S A (1993) 3.11
Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. AIDS Res Hum Retroviruses (1996) 3.01
Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann Neurol (1987) 2.99
A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nat Genet (1996) 2.98
FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardium. Cell (2000) 2.86
Aseptic meningitis and encephalitis: the role of PCR in the diagnostic laboratory. J Clin Microbiol (1997) 2.76
The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr (1990) 2.65
Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet (1980) 2.63
HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc Natl Acad Sci U S A (1989) 2.60
All members of the MHC multigene family respond to thyroid hormone in a highly tissue-specific manner. Science (1986) 2.57
Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy. J Biol Chem (1992) 2.55
Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy. Nat Med (2000) 2.52
HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. N Engl J Med (1980) 2.52
Diagnosis of viral infections of the central nervous system: clinical interpretation of PCR results. Lancet (1997) 2.50
Apoptosis and heart failure: A critical review of the literature. Circ Res (2000) 2.48
HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A (1999) 2.45
Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J (1993) 2.44
Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals. J Clin Invest (1987) 2.37
Chronic inflammatory arthropathy associated with HTLV-I. Lancet (1989) 2.28
Immunogenicity of human amniotic epithelial cells after transplantation into volunteers. Lancet (1981) 2.23
Mechanism of endothelial cell shape change and cytoskeletal remodeling in response to fluid shear stress. J Cell Sci (1996) 2.18
Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet (1996) 2.17
Selection forces and constraints on retroviral sequence variation. Science (2001) 2.17
Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects. Circulation (1995) 2.15
Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation. Circ Res (2000) 2.14
Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants. J Immunol (1986) 2.13
Preliminary report: dramatic rise in renal allograft failure rate. Lancet (1990) 2.09
Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle Nerve (1998) 2.06
The cardiac tissue-restricted homeobox protein Csx/Nkx2.5 physically associates with the zinc finger protein GATA4 and cooperatively activates atrial natriuretic factor gene expression. Mol Cell Biol (1998) 2.05
Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res (1998) 2.01
Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology (1992) 1.94
Cytotoxic T-cell response to respiratory syncytial virus in mice. J Virol (1985) 1.92
Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol (1995) 1.91
Failure of long surviving, passively enhanced kidney allografts to provoke T-dependent alloimmunity. I. Retransplantation of (AS X AUG)F1 kidneys into secondary AS recipients. J Exp Med (1979) 1.88
Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood (2000) 1.87
Angiotensin II induces c-fos mRNA in aortic smooth muscle. Role of Ca2+ mobilization and protein kinase C activation. J Biol Chem (1989) 1.83
Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine. Rheumatology (Oxford) (2001) 1.82
Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia. Blood (2001) 1.80
Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis. Lancet (1987) 1.80
Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the tax gene and their association with different risks for HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis (2000) 1.80
Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children. J Virol (2000) 1.79
Cardiac and extracardiac expression of Csx/Nkx2.5 homeodomain protein. Circ Res (1998) 1.78
Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis. Lancet (1991) 1.76
Quality of life following radiofrequency ablation of dysplastic Barrett's esophagus. Endoscopy (2010) 1.75
Genetic polymorphism within HLA-A*02: significant allelic variation revealed in different populations. Tissue Antigens (1995) 1.70
D-Penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR3. J Rheumatol (1984) 1.69
Long-term persistence of activated cytotoxic T lymphocytes after viral infection of the central nervous system. J Exp Med (1998) 1.68
Blood transfusion and HTLV-I associated myelopathy. Lancet (1986) 1.67
Rapid definition of five novel HLA-A*3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by elispot and intracellular cytokine staining assays. J Virol (2001) 1.63
Ocular manifestations in patients infected with human T-lymphotropic virus type I. Jpn J Ophthalmol (1989) 1.63
Direct quantitation of rapid elimination of viral antigen-positive lymphocytes by antiviral CD8(+) T cells in vivo. Eur J Immunol (2000) 1.61
A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. Gastroenterology (2001) 1.60
Increased replication of HTLV-I in HTLV-I-associated myelopathy. Ann Neurol (1989) 1.60
Comprehensive, serologically equivalent DNA typing for HLA-B by PCR using sequence-specific primers (PCR-SSP). Tissue Antigens (1995) 1.59
Signal transduction pathways of angiotensin II--induced c-fos gene expression in cardiac myocytes in vitro. Roles of phospholipid-derived second messengers. Circ Res (1993) 1.59
Production of beta 2-microglobulin by normal and malignant human cell lines and peripheral lymphocytes. Transplant Rev (1974) 1.57